InvestorsHub Logo
Post# of 252501
Next 10

BTH

Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: DewDiligence post# 149841

Tuesday, 10/02/2012 2:21:07 PM

Tuesday, October 02, 2012 2:21:07 PM

Post# of 252501
And, as usual, you slice and dice words.

Perhaps I should have said in the original message post: Daiichi isn't known for preclinical through late stage development of oncology drugs - they're more of a CV company. Hence, their description on their own website as "We currently market therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome and metastatic melanoma." (the last of which they got through acquisition - not because they developed it internally in any early stage of the development.

If I knew I was being graded on language wording here, I probably would have been more careful.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.